|
 |
Here are headlines and news links for news made public by companies followed in J Taylor’s Gold, Energy & Tech Stocks for the first three days of this work week. In my view the most significant news came from Lion One on Wednesday and NerveGen on Tuesday.
Nervgen Pharma has been focused primarily with NVG-291 a drug it has developed to help injured spinal corde repair itself. It has been demonstrated to work effectively in enabling spinal cord tissue in mice to self-repair and there are unofficial reports and rumors of very significant progress taking place in Phase 2 trials on humans at a single sight in Chicago. On Tuesday, there are a few investors taking note of this exciting story evidenced by the share price increase on Wednesday, June 16.
 |
Wednesday, June 16, 2024
C3 AI Delivers Production Increases Across Holcim's Global Network
https://www.stockwatch.com/News/Item/U-b20240626435269-U!AI-20240626/U/AI
Irving Resources closes $1.09-million private placement
https://www.stockwatch.com/News/Item/Z-C!IRV-3570190/C/IRV
Eskay Mining, P2 Gold call off merger
https://www.stockwatch.com/News/Item/Z-C!ESK-3570200/C/ESK
Lion One's Tuvatu recovers 1,370 oz Au in June to date
https://www.stockwatch.com/News/Item/Z-C!LIO-3570338/C/LIO
Nevada King Gold begins drilling at Atlanta
https://www.stockwatch.com/News/Item/Z-C!NKG-3570220/C/NKG
Tuesday, June 25, 2024
Brixton Metals Begins Drilling at its Cirque Copper Porphyry Target
https://brixtonmetals.com/brixton-metals-begins-drilling-at-its-cirque-copper-porphyry-target/
Contango Announces First Gold Pour at Manh Choh on July 8, 2024
https://www.stockwatch.com/News/Item/U-b20240625414183-U!CTGO-20240625/U/CTGO
Copaur Minerals begins drilling at Williams
https://www.stockwatch.com/News/Item/Z-C!CPAU-3569591/C/CPAU
ExxonMobil and EV battery maker SK On sign MOU regarding
https://www.stockwatch.com/News/Item/U-b20240624739385-U!XOM-20240625/U/XOM
Lahontan Completes Phase Two of 2024 Drilling at Santa Fe
Lahontan Completes Phase 2 Drilling at Santa Fe
NervGen to Advance NVG-300 for thee Application
Nervgen Pharma to develop NVG-300 for three indications
Novo Updates on Becher Exploration
https://www.stockwatch.com/News/Item/Z-C!NVO-3569645/C/NVO
Monday, June 24, 2024
Eskay & P2 Mobilizes Exploration Crews to Eskay-Corey Property
Eskay & P2 Agree to Business Consolidation
Kuya Silver Initiates 2024 Silver Kings Exploration Program to Drill
Red Pine Completes Verification of Gold Assay Results
Red Pine Completes Assay Verification
+
You're currently a free subscriber to J Taylor's Gold Energy & Tech Stocks. For the full experience, upgrade your subscription.
| ||||||||
